BACE1 and Alzheimer disease: In conclusion, our findings demonstrate that early pharmacological intervention with a BACE1-inhibitor could halt the pathological cascade leading to the loss of spines and neurons in the APP knock-in mouse model of AD by enhancing the structural plasticity of dendritic spines in the hippocampal CA1 stratum oriens layer.